Clinical trial

Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits

NCT04352101

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Bupropion XL Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Escitalopram Normalized identity: escitalopramView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-09-23

PhasePHASE4

Conditions

Major Depressionverified · MONDO: major depressive disorder

Interventions

Bupropion XLDRUG

EscitalopramDRUG · verified · RxNorm: escitalopram

Sponsors & collaborators

Emory Universitylead sponsor

National Institute of Mental Health (NIMH)collaborator

Mapped research locations

AtlantaGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04352101 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.